These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25342374)

  • 21. Pulmonary manifestations of polymyositis/dermatomyositis.
    Hallowell RW; Ascherman DP; Danoff SK
    Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
    Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
    Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease.
    Gono T; Kawaguchi Y; Sugiura T; Ichida H; Takagi K; Katsumata Y; Hanaoka M; Okamoto Y; Ota Y; Yamanaka H
    Rheumatology (Oxford); 2010 Oct; 49(10):1878-81. PubMed ID: 20601655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
    Sharma N; Putman MS; Vij R; Strek ME; Dua A
    J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
    Mira-Avendano IC; Parambil JG; Yadav R; Arrossi V; Xu M; Chapman JT; Culver DA
    Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary complications of inflammatory myopathy.
    Ascherman DP
    Curr Rheumatol Rep; 2002 Oct; 4(5):409-14. PubMed ID: 12217246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine treatment for interstitial pneumonitis associated with dermatomyositis/polymyositis.
    Maeda K; Komuta K; Kuritani T; Igarashi T
    Intern Med; 1998 Jan; 37(1):103. PubMed ID: 9510414
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].
    Nuri K; Kotani T; Takeuchi T; Shoda T; Makino S; Hanafusa T
    Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):444-8. PubMed ID: 20608089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
    Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S
    Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary involvement in polymyositis and dermatomyositis].
    Tillie-Leblond I; Colin G; Lelong J; Cadranel J
    Rev Mal Respir; 2006 Dec; 23(6):671-80. PubMed ID: 17202971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of interstitial pneumonia associated with polymyositis/dermatomyositis with cyclosporin A].
    Harigai M; Takagi K; Hara M
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):410-3. PubMed ID: 10726476
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
    Yoshida T; Koga H; Saitoh F; Sakamoto M; Harada M; Yoshida H; Sakisaka S; Sata M
    Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
    Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease.
    Kato Y; Yamamoto T
    Int J Rheum Dis; 2017 May; 20(5):660-661. PubMed ID: 28397348
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus for antisynthetase syndrome with interstitial lung disease?
    Polosa R; Edwards CJ
    Eur Respir J; 2008 Jul; 32(1):244-5; author reply 245-6. PubMed ID: 18591348
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary manifestations of the idiopathic inflammatory myopathies.
    Kalluri M; Oddis CV
    Clin Chest Med; 2010 Sep; 31(3):501-12. PubMed ID: 20692542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
    Shimojima Y; Ishii W; Matsuda M; Kishida D; Ikeda SI
    J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis.
    Chen YJ; Wu CY; Shen JL
    Acta Derm Venereol; 2007; 87(1):33-8. PubMed ID: 17225013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyositis-dermatomyositis-associated interstitial lung disease.
    Douglas WW; Tazelaar HD; Hartman TE; Hartman RP; Decker PA; Schroeder DR; Ryu JH
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1182-5. PubMed ID: 11673206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.